Insider Transactions in Q1 2023 at Galectin Therapeutics Inc (GALT)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,175
+1.08%
|
$18,350
$2.1 P/Share
|
|
Mar 15
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,140
+1.21%
|
$10,140
$1.9 P/Share
|
|
Mar 01
2023
|
Joel Lewis President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
75,529
-8.43%
|
$151,058
$2.07 P/Share
|
|
Feb 28
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,308
+1.03%
|
$18,616
$2.07 P/Share
|
|
Feb 21
2023
|
Kary Eldred |
BUY
Open market or private purchase
|
Direct |
1,000
+2.07%
|
$1,000
$1.59 P/Share
|
|
Feb 16
2023
|
Joel Lewis President and CEO |
BUY
Open market or private purchase
|
Indirect |
1,000
+50.0%
|
$1,000
$1.52 P/Share
|
|
Feb 15
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,380
+1.49%
|
$13,380
$1.44 P/Share
|
|
Feb 07
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
143,836
+14.14%
|
$143,836
$1.43 P/Share
|
|
Jan 31
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,086
+2.03%
|
$15,086
$1.16 P/Share
|
|
Jan 26
2023
|
Richard E Uihlein |
BUY
Grant, award, or other acquisition
|
Direct |
36,036
+0.45%
|
$36,036
$1.11 P/Share
|
|
Jan 25
2023
|
Kary Eldred |
BUY
Open market or private purchase
|
Direct |
1,300
+2.74%
|
$1,300
$1.11 P/Share
|
|
Jan 13
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,351
+2.1%
|
$15,351
$1.14 P/Share
|